SEC Form 4 · accession 0001019687-16-004822
CV Sciences, Inc. · CVSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph D Dowling
Officer — Chief Financial Officer
Period of report
Dec 28, 2015
Accepted (ET)
Jan 14, 2016 · 1:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001510964
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $0.155 | Dec 28, 2015 | A | 150,000 | A | — | Dec 27, 2025 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1The option is durational-based, and vests and becomes exercisable as follows: Fifty percent (50%) of the shares subject to the option will be vested on September 23, 2016 with the remainder vesting in twelve (12) successive equal monthly installments measured from September 23, 2016.